Skin Care News

Suntegrity Skincare has issued a voluntary recall of nine Impeccable Skin Sunscreen Foundation lots, according to a press release from the FDA.

Hormone replacement therapy may render the skin of postmenopausal women both more prone to inflammation and more capable of repairing itself, according to a study.

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

The FDA has approved the expanded use area of Klisyri to up to 100 cm2 on the face and scalp for the treatment of actinic keratosis, Almirall announced in a press release.

CLEVELAND — In this video perspective from the Cleveland Clinic’s Medical Dermatology Therapy Update III meeting, Adam Brown, MD, a rheumatologist at the institution, discusses what to look for in leukocytoclastic, or cutaneous, vasculitis.

CLEVELAND — While new treatments for cutaneous lupus are on the horizon, sunscreen remains the best way to offset effects, according to J. Michelle Kahlenberg, MD, PhD.

Based on a variant’s impact on type VII collagen protein function, patients with recessive dystrophic epidermolysis bullosa can be categorized into clinically meaningful subgroups to better guide disease management, according to a study.

Isotretinoin is associated with a clinically marginal increased risk for severe adverse events, leading researchers to advise routine blood testing commence shortly after initiation, according to a study.

Secukinumab did not reach proof of concept in patients with lichen planus, according to results of a phase 2 study.

Actinic keratosis lesions were reduced and quality of life improved following once-daily topical tirbanibulin treatment, according to a study.